Alimera Sciences' ILUVIEN(R) Receives Marketing Authorization in France for the Treatment of Chronic Diabetic Macular Edema

Alimera announced it has received authorization to market ILUVIENT for the treatment of vision impairment associated with chronic diabetic macular edema (DME) in France.... [more]

View complete Press Release article